TrialHaematologica2015

Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study.

Patrice Chevallier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.